Abstract
Venous thromboembolism comprises deep vein thrombosis (DVT) and pulmonary embolism (PE). Acute venous thromboembolism (VTE) is a serious and potentially fatal disorder which often complicates the course of hospitalized patients, but also affects ambulatory and otherwise healthy people. The annual incidence of venous thromboembolism is 1 to 2 cases per 1000 person and the risk of the disorder rises exponentially with age, from an annual rate of less than 5 per 100,000 children to greater than 400 per 100,000 adults older than 80 years.
MeSH terms
-
Activated Protein C Resistance / diagnosis
-
Activated Protein C Resistance / drug therapy
-
Activated Protein C Resistance / physiopathology*
-
Adult
-
Anticoagulants / therapeutic use
-
Factor V*
-
Humans
-
Male
-
Pulmonary Embolism / etiology*
-
Risk Assessment
-
Risk Factors
-
Venous Thromboembolism / diagnosis
-
Venous Thromboembolism / drug therapy
-
Venous Thromboembolism / etiology*
-
Venous Thrombosis / diagnosis
-
Venous Thrombosis / drug therapy
-
Venous Thrombosis / etiology*
-
Young Adult
Substances
-
Anticoagulants
-
factor V Leiden
-
Factor V